Robotic-assisted esophagectomy leads to significant reduction in postoperative acute pain: A retrospective clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027859

Enrollment

500

Registered

2022-01-25

Start date

2021-02-06

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C15

Interventions

Group 1: robotic-assisted minimal invasive esophagectomy (RAMIE) Group 2: hybrid esophagectomy (abdominal: laparoscopic thoracic: open) Group 3: open esophagectomy

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Histologically confirmed thoracic or abdominal esophageal carcinoma, Surgically resectable at the time of diagnosis or after neoadjuvant treatment, abdomino-thoracic Icor-Lewis esophagectomy in RAMIE, hybrid or open surgical technique. A retrospective study where all patients were evaluated between 01.01.2012 and 30.12.2021.

Exclusion criteria

Exclusion criteria: cervical esophageal carcinoma, carcinoma of the gastroesophageal junction classified Siewert III, intraoperative termination following diagnostic laparoscopy

Design outcomes

Primary

Measure	Time frame
postoperative analgesic consumption (morphine miligram equivalent)	—

Secondary

Measure	Time frame
postoperative pain (NRS pain scale), postoperative hospital stay (days), intensive care unit stay (days), blood loss (ml), complications (Clavien-Dindo classification).	—

Countries

Germany

Contacts

Public ContactJens Hölzen

Universitätsklinikum Münster (UKM)Klinik für Allgemein-, Viszeral- und Transplantationschirurgie

Jenspeter.Hoelzen@ukmuenster.de+49 251 8351493

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026